Position in ENTA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$11,114,690
-$2,843,747 QoQ
Shares Held
880,023
-0.6% QoQ
Ownership
3.03%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $658,704,928 across 179 Biotechnology names. ENTA ranks #11 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,900,824 | $178,905,554 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
151,191 | $116,816,214 | |
| 3 | LEGN |
Legend Biotech Corp
|
1,527,336 | $27,629,508 | |
| 4 | TBPH |
Theravance Biopharma, Inc.
|
1,276,576 | $20,718,828 | |
| 5 | RIGL |
Rigel Pharmaceuticals Inc
|
666,426 | $18,020,159 | |
| 6 | IMCR |
Immunocore Holdings plc
|
501,091 | $15,107,893 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
1,547,593 | $15,042,603 | |
| 8 | PBYI |
Puma Biotechnology, Inc.
|
2,041,759 | $13,046,840 |
All Filings in ENTA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,114,690 | 880,023 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $13,958,437 | 885,126 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $10,378,432 | 867,037 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,554,799 | 867,037 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $4,786,044 | 867,037 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $4,884,188 | 849,424 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,800,032 | 849,424 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $11,017,029 | 849,424 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $14,909,024 | 853,896 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $7,932,103 | 842,944 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,129,894 | 548,782 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,152,433 | 100,581 | Shares | Defined | 2023-08-07 | |
| 2022-06-30 | $2,015,592 | 42,640 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $5,108,802 | 71,773 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $9,910,369 | 132,527 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $13,557,138 | 238,640 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $16,152,198 | 367,012 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $22,873,333 | 463,774 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $19,682,339 | 467,514 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $21,476,084 | 469,115 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $20,756,060 | 413,385 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $17,685,851 | 343,882 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||